Cargando…

Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21) exerts wide-range effects on carbohydrate and lipid metabolism. However, its perturbation in type 2 diabetes mellitus (T2DM) remains elusive. Besides, previous human studies in T2DM simply investigated fasting or stimulated levels of FGF21. The current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jingyi, Yu, Haoyong, Mo, Yifei, Ma, Xiaojing, Hao, Yaping, Lu, Wei, Li, Huating, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634968/ https://www.ncbi.nlm.nih.gov/pubmed/26540514 http://dx.doi.org/10.1371/journal.pone.0142207

Ejemplares similares

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
por: Shen, Yun, et al.
Publicado: (2013)

Beneficial Effects of an 8-Week, Very Low Carbohydrate Diet Intervention on Obese Subjects
por: Gu, Yunjuan, et al.
Publicado: (2013)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma
por: Li, Xu, et al.
Publicado: (2017)

Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Li, Huating, et al.
Publicado: (2018)

Associations of Common Variants at APLN and Hypertension in Chinese Subjects with and without Diabetes
por: Zhang, Rong, et al.
Publicado: (2012)

Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals
por: Hao, Yaping, et al.
Publicado: (2013)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
por: Wu, Liang, et al.
Publicado: (2017)

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
por: Ye, Dewei, et al.
Publicado: (2016)

Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012)

Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway
por: Dou, Jianxin, et al.
Publicado: (2014)

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
por: Shen, Yun, et al.
Publicado: (2017)

Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
por: Lu, Jingyi, et al.
Publicado: (2018)

Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy
por: Huang, Yan, et al.
Publicado: (2012)

Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients
por: Yu, Haoyong, et al.
Publicado: (2012)

Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
por: Chen, Shuqin, et al.
Publicado: (2017)

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women
por: Bao, Yuqian, et al.
Publicado: (2011)

Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
por: Mo, Yifei, et al.
Publicado: (2020)

Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
por: Ni, Jie, et al.
Publicado: (2013)

A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Chen, Haibing, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients
por: Zhang, Lei, et al.
Publicado: (2016)

Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals
por: Ni, Yan, et al.
Publicado: (2015)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Associations of Serum 25-Hydroxyvitamin D(3) Levels with Visceral Adipose Tissue in Chinese Men with Normal Glucose Tolerance
por: Hao, Yaping, et al.
Publicado: (2014)

Inverse Association of Serum Vitamin D in Relation to Carotid Intima-Media Thickness in Chinese Postmenopausal Women
por: Hao, Yaping, et al.
Publicado: (2015)

Positive Relationship between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population
por: Luo, Yuqi, et al.
Publicado: (2014)

Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population
por: Luo, Yuqi, et al.
Publicado: (2015)

Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes
por: Hu, Xiang, et al.
Publicado: (2016)

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m(2) and Type 2 diabetes: a 6-month follow-up
por: Tu, Yinfang, et al.
Publicado: (2015)

Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey
por: Bao, Yuqian, et al.
Publicado: (2010)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
por: Shen, Yun, et al.
Publicado: (2020)

Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy
por: Guo, Kaifeng, et al.
Publicado: (2015)

Serum Glycated Albumin Is Inversely Influenced by Fat Mass and Visceral Adipose Tissue in Chinese with Normal Glucose Tolerance
por: Wang, Feifei, et al.
Publicado: (2012)

Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass
por: Tu, Yinfang, et al.
Publicado: (2014)

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose
por: Zhang, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rbkqvojlnmqcnq5q041k60u8dk